Marlborough Stirling has signed a deal to deliver the administration system behind Royal Liver's innovative new IFA division when it launches later this year.
Although few details are being given away at this stage, it is believed the Royal Liver operation is attempting to develop an "innovative" new system, targeted solely at financial advisers. Under the contract, Marlborough Stirling will use its existing Exweb portal to deliver Royal Liver’s electronic quotation and transactions system and hook it up to an extension of Marlborough’s straight-processing regime, known as Lamda, to deliver automated online underwriting, acceptance of the majority of new business cases without needing ‘human’ clearance, as well as internet-based claims managem...
To continue reading this article...
Join Professional Adviser for free
Signup and gain exclusive members-only insights
- Unlimited access to real-time news, industry insights and market intelligence
- Stay ahead of the curve with spotlights on emerging trends and technologies
- Receive breaking news stories straight to your inbox in the daily newsletters
- Make smart business decisions with the latest developments in regulation, investing retirement and protection
- Members-only access to the editor’s weekly Friday commentary
- Be the first to hear about our events and awards programmes
